Magnesium lithospermate B improves metabolic changes in high-fat diet-fed rats with metabolic syndrome

Journal of Functional Foods

Volumn 14, Issue , 2015, Pages 163-173

  Chen, Ying Jie ^a   Lo, Yuan Hao ^a   Chen, Yi Ting ^a   Lai, Nai Wei ^a   Lin, Nan Hei ^a   Chung, Tse Yu ^a   Chen, Wen Ying ^a   Tzen, Jason T C ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

High fat diets; Insulin resistance; Magnesium lithospermate B; Metabolic syndrome; Steatosis

Indexed keywords

RATTUS; RODENTIA; SALVIA MILTIORRHIZA;

EID: 84926321076     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.01.042     Document Type: Article

References (48)

1. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine 2006, 23:469-480.
2. Antuna-Puente B., Feve B., Fellahi S., Bastard J.P. Adipokines: The missing link between insulin resistance and obesity. Diabetes & Metabolism 2008, 34:2-11.
3. Buettner R., Schölmerich J., Bollheimer L.C. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity 2007, 15:798-808.
4. +-ATPase inhibitors. Acta Pharmacologica Sinica 2011, 32:141-151.
5. Chen W., Tang F., Xie B., Chen S., Huang H., Liu P. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. European Journal of Pharmacology 2012, 674:359-364.
6. Chen W.Y., Chen C.J., Liu C.H., Mao F.C. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. Biochemical and Biophysical Research Communications 2010, 397:459-464.
7. Czech M.P., Tencerova M., Pedersen D.J., Aouadi M. Insulin signalling mechanisms for triacylglycerol storage. Diabetologia 2013, 56:949-964.
8. den Boer M., Voshol P.J., Kuipers F., Havekes L.M., Romijn J.A. Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:644-649.
9. Drew B.G., Duffy S.J., Formosa M.F., Natoli A.K., Henstridge D.C., Penfold S.A., Thomas W.G., Mukhamedova N., de Courten B., Forbes J.M., Yap F.Y., Kaye D.M., van Hall G., Febbraio M.A., Kemp B.E., Sviridov D., Steinberg G.R., Kingwell B.A. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 2009, 119:2103-2111.
10. Ferrannini E., Mari A. β-Cell function in type 2 diabetes. Metabolism: Clinical and Experimental 2014, 63:1217-1227.
11. Ferré P., Foufelle F. Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes, Obesity and Metabolism 2010, 12:83-92.
12. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 1957, 226:497-509.
13. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 2004, 114:1752-1761.
14. Gao H.W., Zhang M.M., Liu Y.L., Xu Q.M., Yang S.L. Anticomplement activity of ginsenosides from Panax ginseng. Journal of Functional Foods 2013, 5:498-502.
15. Hsiao P.J., Kuo K.K., Shin S.J., Yang Y.H., Lin W.Y., Yang J.F., Chiu C.C., Chuang W.L., Tsai T.R., Yu M.L. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. Journal of Gastroenterology and Hepatology 2007, 22:2118-2123.
16. Hsu W.H., Liao T.H., Lee B.H., Hsu Y.W., Pan T.M. Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-γ activation. Journal of Functional Foods 2013, 5:124-132.
17. Hu X., Wang M., Bei W., Han Z., Guo J. The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome. Journal of Translational Medicine 2014, 12:47.
18. Huang M., Xie Y., Chen L., Chu K., Wu S., Lu J., Chen X., Wang Y., Lai X. Antidiabetic effect of the total polyphenolic acids fraction from Salvia miltiorrhiza Bunge in diabetic rats. Phytotherapy Research 2012, 26:944-948.
19. Hur K.Y., Kim S.H., Choi M.A., Williams D.R., Lee Y.H., Kang S.W., Yadav U.C., Srivastava S.K., Jung M., Cho J.W., Kim S.G., Kang E.S., Lee E.J., Lee H.C. Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway. Atherosclerosis 2010, 211:69-76.
20. Hur K.Y., Seo H.J., Kang E.S., Kim S.H., Song S., Kim E.H., Lim S., Choi C., Heo J.H., Hwang K.C., Ahn C.W., Cha B.S., Jung M., Lee H.C. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury. European Journal of Pharmacology 2008, 586:226-233.
21. Ji C., Chan C., Kaplowitz N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. Journal of Hepatology 2006, 45:717-724.
22. Ji W., Gong B.Q. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. Journal of Ethnopharmacology 2008, 119:291-298.
23. Jiang R.W., Lau K.M., Hon P.M., Mak T.C., Woo K.S., Fung K.P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Current Medicinal Chemistry 2005, 12:237-246.
24. Jung S.H., Seol H.J., Jeon S.J., Son K.H., Lee J.R. Insulin-sensitizing activities of tanshinones, diterpene compounds of the root of Salvia miltiorrhiza Bunge. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2009, 16:327-335.
25. Kasimu R., Tanaka K., Tezuka Y., Gong Z.N., Li J.X., Basnet P., Namba T., Kadota S. Comparative study of seventeen Salvia plants: Aldose reductase inhibitory activity of water and MeOH extracts and liquid chromatography-mass spectrometry (LC-MS) analysis of water extracts. Chemical & Pharmaceutical Bulletin 1998, 46:500-504.
26. Koonen D.P.Y., Jacobs R.L., Febbraio M., Young M.E., Soltys C.L.M., Ong H., Vance D.E., Dyck J.R.B. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56:2863-2871.
27. Lee B.H., Pan T.M. Dimerumic acid, a novel antioxidant identified from Monascus-fermented products exerts chemoprotective effects: Mini review. Journal of Functional Foods 2013, 5:2-9.
28. Lee B.W., Chun S.W., Kim S.H., Lee Y., Kang E.S., Cha B.S., Lee H.C. Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1. Toxicology and Applied Pharmacology 2011, 252:47-54.
29. Lei X.L., Chiou G.C. Studies on cardiovascular actions of Salvia miltiorrhiza. American Journal of Chinese Medicine 1986, 14:26-32.
30. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414:821-827.
31. Nguyen P., Leray V., Diez M., Serisier S., Bloc'h J.L., Siliart B., Dumon H. Liver lipid metabolism. Journal of Animal Physiology and Animal Nutrition 2008, 92:272-283.
32. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
33. Shashidhar M.G., Giridhar P., Udaya Sankar K., Manohar B. Bioactive principles from Cordyceps sinensis: A potent food supplement - A review. Journal of Functional Foods 2013, 5:1013-1030.
34. Shi J., Shahidi F., Ho C.T. Asian functional foods 2005, CRC Press, New York.
35. Shulman G.I. Cellular mechanisms of insulin resistance. The Journal of Clinical Investigation 2000, 106:171-176.
36. Tailleux A., Wouters K., Staels B. Roles of PPARs in NAFLD: Potential therapeutic targets. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2012, 1821:809-818.
37. Tan Y., Kamal M.A., Wang Z.Z., Xiao W., Seale J.P., Qu X. Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome. Clinical Science 2011, 120:297-305.
38. Tan Y., Lao W., Xiao L., Wang Z., Xiao W., Kamal M.A., Seale J.P., Qu X. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome with Chinese herbal extracts in high-fat-diet fed rats. Evidence-based Complementary and Alternative Medicine 2013, 2013. 306738.
39. +-ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacologica Sinica 2007, 28:609-615.
40. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
41. Wu W.Y., Wang Y.P. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacologica Sinica 2012, 33:1119-1130.
42. Xia S.F., Xie Z.X., Qiao Y., Li L.R., Cheng X.R., Duan X.M., Tang X., Shi Y.H., Le G.W. Salvianolic acid B counteracts cognitive decline triggered by oxidative stress in mice fed with high-fat diets. Journal of Functional Foods 2014, 11:278-292.
43. Xie W., Du L. Diabetes is an inflammatory disease: Evidence from traditional Chinese medicines. Diabetes, Obesity and Metabolism 2011, 13:289-301.
44. Zeyda M., Stulnig T.M. Obesity, inflammation, and insulin resistance - A mini-review. Gerontology 2009, 55:379-386.
45. Zhang W., Zheng L., Zhang Z., Hai C.X. Protective effect of a water-soluble polysaccharide from Salvia miltiorrhiza Bunge on insulin resistance in rats. Carbohydrate Polymers 2012, 89:890-898.
46. Zhao G.R., Zhang H.M., Ye T.X., Xiang Z.J., Yuan Y.J., Guo Z.X., Zhao L.B. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food and Chemical Toxicology 2008, 46:73-81.
47. Zhou L., Zuo Z., Chow M.S.S. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. The Journal of Clinical Pharmacology 2005, 45:1345-1359.
48. Zimmet P.Z., McCarty D.J., de Courten M.P. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. Journal of Diabetes and Its Complications 1997, 11:60-68.